Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: Correlation with pathological characteristics

Author:

Bao Jingwen1,Nie Zehua1,Wang Quanwen1,Chen Yanling2,Wang Kun3,Liu Xinjiang4

Affiliation:

1. Hexi University

2. First Affiliated Hospital of Sun Yat-sen University

3. Binzhou Medical College Hospital

4. pudong hospital, fudan university

Abstract

Abstract

Objective To explore the factors that influence the contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) classification of combined hepatocellular-cholangiocarcinoma (cHCC-ICC). Methods Between September 2014 to July 2020, the CEUS features of 58 patients with pathologically confirmed cHCC-ICC were retrospectively evaluated and assigned according to the CEUS LI-RADS (version 2017). The pathological characteristics of nodules categorizing as different CEUS LI-RADS categories were compared. Multivariate logistic regression analysis was conducted to explore potential factors that may influence the CEUS LI-RADS classification of cHCC-ICC. Results According to CEUS LI-RADS, 32.8% (19/58), 63.8% (37/58), and 3.4% (2/58) were categorized as LR-5, LR-M, and LR-TIV, respectively. There was significant difference between the LR-M and LR-5 groups with regard to the pathological grade, nodule size, and HCC/ICC-component ratio of cHCC-ICC. Multivariate logistic regression analysis identified tumor size and the relative proportions of hepatocellular carcinomas (HCC) and intrahepatic cholangiocarcinomas (ICC) components within cHCC-ICC as the independent influencing factors. Conclusion Tumor size and the relative proportion of HCC and ICC components within the nodule had a significant impact on the CEUS LI-RADS classification of cHCC-ICC.

Publisher

Springer Science and Business Media LLC

Reference38 articles.

1. Combined hepatocellular-cholangiocarcinoma: An update;Beaufrère A;J Hepatol,2021

2. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification;Akiba J;Am J Surg Pathol,2013

3. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers;Wakizaka K;J Gastroenterol Hepatol,2019

4. Leoni S, Sansone V, Lorenzo S, Ielasi L, Tovoli F, Renzulli M, et al. Treatment of Combined Hepatocellular and Cholangiocarcinoma. Cancers (Basel) 2020;12.

5. Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection;Song P;Cancer Med,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3